Sequelae of storage in Fabry disease - Pathology and comparison with other lysosomal storage diseases

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 92, Issue 443, 2003, Pages 46-53

  Elleder, M ^a  

^a Charles University in Prague and General University Hospital in Prague   (Czech Republic)

Author keywords

Arteriopathy; Cardiac hypertrophy; Endothelial storage; Genital system involvement; Nephropathology

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; PROTEIN;

ADOLESCENT; ADRENAL CORTEX; ADULT; ARTERY DISEASE; BIOACCUMULATION; BIOPSY; CAPILLARY BASEMENT MEMBRANE; CAPILLARY ENDOTHELIUM; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; FABRY DISEASE; FEMALE; GLOMERULUS; HEART HYPERTROPHY; HEART MUSCLE CELL; HEMANGIOKERATOMA; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE CELL; LIVER; LIVER SINUSOID; LYSOSOME STORAGE DISEASE; MALE; MESANGIUM CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENAL ARTERY; SAMPLE;

EID: 1642455933     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2003.tb00222.x     Document Type: Conference Paper

References (54)

1. Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. 8th edition. New York: McGraw-Hill; 2001: 3733-74
2. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human α-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 2001; 345: 9-16
3. Schiffmann R, Kopp JB, Austin HA, 3rd, Sabnis S, Moore DF, Weibel T, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001; 285: 2743-9
4. Hiraizumi Y, Kanoh M, Shigematsu H, Yamashina M, Kondo I. A case of Fabry disease with granulomatous interstitial nephritis. Nippon Jinzo Gakkai Shi 1995; 11: 655-61
5. Elleder M, Bradova V, Smid F, Budesinsky M, Harzer K, Kustermann-Kuhn B, et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 1990; 417: 449-55
6. Hulkova H, Ledvinova J, Poupetova H, Bultas J, Zeman J, Elleder M. [Postmortem diagnosis of Fabry disease in a female heterozygote leading to the detection of undiagnosed manifest disease in the family] (in Czech). Cas Lek Cesk 1999; 138: 660-4
7. Ledvinova J, Poupetova H, Hanackova A, Pisacka M, Elleder M. Blood group B glycosphingolipids in alpha-galactosidase deficiency (Fabry disease): influence of secretor status. Biochim Biophys Acta 1997; 1345: 180-7
8. Wenger DA, Williams C, Screening for lysosomal disorders. In: Hommes FA. editor. Techniques in diagnostic human biochemical genetics. New York: Willey-Liss; 1991: 587-617
9. Cable WJ, Dvorak AM, Osage JE, Kolodny EH. Fabry disease: significance of ultrastructural localization of lipid inclusions in dermal nerves. Neurology 1982; 32: 347-53
10. Elleder M, Ledvinova J, Vosmik F, Zeman J, Stejskal D, Lageron A. An atypical ultrastructural pattern in Fabry's disease: a study on its nature and incidence in 7 cases. Ultrastruct Pathol 1990; 14: 467-74
11. Linhart A, Lubanda JC, Palecek T, Bultas J, Karetova D, Ledvinova J, et al. Cardiac manifestations in Fabry disease. J Inherit Metab Dis 2001; 24 Suppl 2: 75-83
12. Bannwart F. [Fabry's disease. Light and electron microscopic cardiac findings 12 years after successful kidney transplantation]. Schweiz Med Wochenschr 1982; 112: 1742-7
13. Ikari Y, Kuwako K, Yamaguchi T. Fabry's disease with complete atrioventricular block: histological evidence of involvement of the conduction system. Br Heart J 1992; 68: 323-5
14. Hayflick S, Rowe S, Kavanaugh-McHugh A, Olson JL, Valle D. Acute infantile cardiomyopathy as a presenting feature of mucopolysaccharidosis VI. J Pediatr 1992; 120: 269-72
15. Towbin JA, Lipshultz SE. Genetics of neonatal cardiomyopathy. Curr Opin Cardiol 1999; 14: 250-62
16. Dangel JH. Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders - clinical and echocardiographic findings in 64 patients. Eur J Pediatr 1998; 157: 534-8
17. Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation 1976; 54: 818-25
18. Michielsen P, Martin JJ, Vanagt E, Vrints C, Gillebert T, Snoeck J. Cardiac involvement in juvenile ceroid lipofuscinosis of the Spielmeyer-Vogt-Sjogren type: prospective noninvasive findings in two siblings. Eur Neurol 1984; 23: 166-72
19. Hofman IL, van der Wal AC, Dingemans KP, Becker AE. Cardiac pathology in neuronal ceroid lipofuscinoses - a clinicopathologic correlation in three patients. Eur J Paediatr Neurol 2001; 5 Suppl A: 213-7
20. Santorelli FM, Tessa A, D'Amati G, Casali C. The emerging concept of mitochondrial cardiomyopathies. Am Heart J 2001; 141: E1
21. Linhart A, Palecek T, Bultas J, Ferguson JJ, Hrudova J, Karetova D, et al. New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J 2000; 139: 1101-8
22. Hillsley RE, Hernandez E, Steenbergen C, Bashore TM, Harrison JK. Inherited restrictive cardiomyopathy in a 74-year-old woman: a case of Fabry's disease. Am Heart J 1995; 129: 199-202
23. Cantor WJ, Butany J, Iwanochko M, Liu P. Restrictive cardiomyopathy secondary to Fabry's disease. Circulation 1998; 98: 1457-9
24. Elleder M. Fabry's disease: absence of storage as a feature of liver sinus endothelium. Acta Histochem 1985; 77: 33-6
25. Minshall RD, Tiruppathi C, Vogel SM, Malik AB. Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 2002; 117: 105-12
26. Vogel SM, Minshall RD, Pilipovic M, Tiruppathi C, Malik AB. Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1512-22
27. Simionescu M, Stancu C, Costache G, Sima A. Endothelial cell response to hyperlipemia. Activation-dysfunction-injury, the protective role of simvastatin. Vascul Pharmacol 2002; 38: 275-82
28. Elleder M. The spleen and storage disorders. In: Cuschieri A, Forbes CD, editors. Disorders of the spleen. Oxford: Blackwell Scientific Publications; 1994: 151-90
29. Fawcett DW. A textbook of histology. New York: Chapman and Hall; 1994
30. Valente M, Cipriani R, Peserico A. Malattia di Fabry. Pathologica 1982; 74: 875-82
31. Voglino A, Paradisi M, Dompe G, Onetti Muda A, Faraggiana T. Angiokeratoma corporis diffusum (Fabry's disease) with unusual features in a female patient. Light- and electron-microscopic investigation. Am J Dermatopathol 1988; 10: 343-8
32. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342-8
33. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001; 108: 807-16
34. von Figura K, Gieselmann V, Jaeken J. Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. 8th edition. New York: McGraw-Hill; 2001: 3695-724
35. Hers HG, De Barsy T. Type II glycogenosis (acid maltase deficiency). In: Hers HG, Van Hoof F, editors. Lysosomes and storage diseases. New York: Academic Press; 1973: 197-261
36. Witcop CJ, White JG, Townsend D, Sedano HO, Cal SX, Babcock M, et al. Ceroid storage disease in Hermansky-Pudlak syndrome: introduction in animal models. In: Nagy Z, editor. Lipofuscin. Budapest and Amsterdam: Akadémiai Kiadó and Elsevier Science Publishers; 1988: 413-36
37. Eguchi M, Poon KC, Spicer SS. Alterations in the proximal nephron of beige mice with the Chediak-Higashi syndrome. Am J Pathol 1982; 106: 95-109
38. Stinchcombe JC, Griffiths GM. Normal and abnormal secretion by haemopoietic cells. Immunology 2001; 103: 10-16
39. Birn H, Fyfe JC, Jacobsen C, Mounier F, Verroust PJ, Orskov H, et al. Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. J Clin Invest 2000; 105: 1353-61
40. Kozyraki R. Cubilin, a multifunctional epithelial receptor: an overview. J Mol Med 2001; 79: 161-7
41. Pueschel SM, O'Shea PA, Alroy J, Ambler MW, Dangond F, Daniel PF, et al. Infantile sialic acid storage disease associated with renal disease. Pediatr Neurol 1988; 4: 207-12
42. Sperl W, Gruber W, Quatacker J, Monnens L, Thoenes W, Fink FM, et al. Nephrosis in two siblings with infantile sialic acid storage disease. Eur J Pediatr 1990; 149: 477-82
43. Maroteaux P, Humbel R, Strecker G, Michalski JC, Mande R. [A new type of sialidosis with kidney disease: nephrosialidosis. I. Clinical, radiological and nosological study]. Arch Fr Pediatr 1978; 35: 819-29
44. Aylsworth AS, Thomas GH, Hood JL, Malouf N, Libert J. A severe infantile sialidosis: clinical, biochemical, and microscopic features. J Pediatr 1980; 96: 662-8
45. Roth KS, Chan JC, Ghatak NR, Mamunes P, Miller WW, O'Brien JS. Acid alpha-neuraminidase deficiency: a nephropathic phenotype? Clin Genet 1988; 34: 185-94
46. D'Azzo A, Andria G, Strisciuglio P, Galjaard H. Galactosialidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. 8th edition. New York: McGraw-Hill; 2001: 3811-26
47. Durand P, Borrone C, Della Cella G. Fucosidosis. J Pediatr 1969; 75: 665-74
48. Thomas GH. Disorders of glycoprotein degradation: alpha-mannosidosis, beta-mannosidosis, fucosidosis and sialidosis. In: Schriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. 8th edition. New York: McGraw-Hill; 2001: 3507-34
49. Ogawa T, Kawai M, Matsui T, Seo A, Aizawa O, Hongo K, et al. Vasospastic angina in a patient with Fabry's disease who showed normal coronary angioaraphic findings. Jpn Circ J 1996; 60: 315-8
50. Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, et al. Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 2001; 32: 1559-62
51. Fisher EA, Desnick RJ, Gordon RE, Eng CM, Griepp R, Goldman ME. Fabry disease: an unusual cause of severe coronary disease in a young man. Ann Intern Med 1992; 117: 221-3
52. Shirai T, Ohtake T, Kimura M, Iwata M, Fujigaki Y, Takayanagi S, et al. Atypical Fabry's disease presenting with cholesterol crystal embolization. Intern Med 2000; 39: 646-9
53. Clarke JT, Stoltz JM, Garner JB. Stability of plasma low density lipoprotein with abnormal glycolipid composition from patients with Fabry's disease. Atherosclerosis 1980; 35: 155-63
54. Nistal M, Paniagua R, Picazo ML. Testicular and epididymal involvement in Fabry's disease. J Pathol 1983; 141: 113-24